Lynette M. Sholl

Brigham and Women's Hospital

Full Professor(heuristic)

Lung Cancer Treatments and Mutations · Pulmonary and Respiratory Medicine

h-index98

i10-index319

Publications1,160

Citations39,640

Grants

No NSF/NIH grants on record.

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 20 of 206

Identification of a Rejection Signature and Distinct Inflammatory Alveolar Macrophage Populations Post–lung Transplantation
Transplantation · 2026-05-18
Revealing the Drivers Underlying Distinct Evolutionary Trajectories in Lung Adenocarcinoma
bioRxiv (Cold Spring Harbor Laboratory) · 2025-12-23
Microbiome analysis of 940 lung cancers in never-smokers reveals lack of clinically relevant associations
Nature Communications · 2025-12-12 · 4 citations
Uncovering the role of LINE-1 in the evolution of lung adenocarcinoma
Nature · 2025-12-10 · 8 citations
Contrastive learning enhances fairness in pathology artificial intelligence systems
Cell Reports Medicine · 2025-12-01 · 5 citations
Presenting Features and Causes of Diagnostic Delays: A Report From the NUT Carcinoma Registry
JCO Precision Oncology · 2025-12-01
Supplementary Figure 27 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025-11-25
Supplementary Table 5 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025-11-25
Supplementary Table 3 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025-11-25
Supplementary Figure 5 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025-11-25
Supplementary Figure 18 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025-11-25
Supplementary Figure 1. from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025-11-25
Supplementary Figure 2 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025-11-25
Supplementary Figure 26 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025-11-25
Supplementary Figure 24 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025-11-25
Supplementary Figure 10 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025-11-25
Supplementary Figure 22. from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025-11-25
Supplementary Figure 13 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025-11-25
Supplementary Figure 11 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025-11-25
Supplementary Figure 23. from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
2025-11-25

Open author page on OpenAlex →